圣诺生物
(688117)
| 流通市值：65.17亿 | | | 总市值：65.17亿 |
| 流通股本：1.57亿 | | | 总股本：1.57亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 520,117,203.2 | 337,569,910.26 | 184,337,043.36 | 456,070,000.1 |
| 营业收入 | 520,117,203.2 | 337,569,910.26 | 184,337,043.36 | 456,070,000.1 |
| 二、营业总成本 | 371,578,612.66 | 234,980,392.74 | 125,838,852.95 | 382,688,895.04 |
| 营业成本 | 225,369,839.38 | 145,539,686.44 | 80,919,678.44 | 191,704,265.08 |
| 税金及附加 | 5,012,187.69 | 3,450,679.68 | 1,284,091.71 | 4,696,116.51 |
| 销售费用 | 41,979,288.93 | 24,196,060.39 | 13,451,348.97 | 66,257,444.57 |
| 管理费用 | 51,746,145.86 | 37,533,332.9 | 22,429,906.19 | 61,663,769.41 |
| 研发费用 | 36,356,680 | 18,139,801.71 | 4,839,101.81 | 49,165,159.73 |
| 财务费用 | 11,114,470.8 | 6,120,831.62 | 2,914,725.83 | 9,202,139.74 |
| 其中:利息费用 | 12,273,533.78 | 7,050,950.58 | 3,282,676.79 | 11,908,840.85 |
| 其中:利息收入 | 1,281,980.34 | 634,904.17 | 156,899.2 | 2,034,608.76 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | -157,000 | -157,000 | -132,000 | 157,000 |
| 加:投资收益 | 1,055,691 | 1,451,653.4 | 2,029,283.39 | 1,715,684.86 |
| 资产减值损失(新) | -9,320,522.86 | -8,175,880.74 | -4,640,498.92 | -10,876,019.72 |
| 信用减值损失(新) | 3,675,902.78 | 5,951,301.63 | 534,298.32 | -7,233,528.39 |
| 其他收益 | 3,712,631.74 | 2,537,061.84 | 478,046 | 4,916,296.86 |
| 四、营业利润 | 147,505,293.2 | 104,196,653.65 | 56,767,319.2 | 62,060,538.67 |
| 加:营业外收入 | 34,885.77 | 23,902.66 | 268 | 245,594.78 |
| 减:营业外支出 | 1,864,105.42 | 1,506,299.49 | 1,245,988.12 | 797,583.33 |
| 五、利润总额 | 145,676,073.55 | 102,714,256.82 | 55,521,599.08 | 61,508,550.12 |
| 减:所得税费用 | 18,704,742.35 | 13,796,400.33 | 8,440,736.82 | 11,673,177.63 |
| 六、净利润 | 126,971,331.2 | 88,917,856.49 | 47,080,862.26 | 49,835,372.49 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 126,971,331.2 | 88,917,856.49 | 47,080,862.26 | 49,835,372.49 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 127,010,169.16 | 88,956,694.45 | 47,119,700.22 | 50,023,708.92 |
| 少数股东损益 | -38,837.96 | -38,837.96 | -38,837.96 | -188,336.43 |
| 扣除非经常损益后的净利润 | 126,074,692.07 | 89,476,305.84 | 47,943,063.53 | 45,612,403.87 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.81 | 0.57 | 0.42 | 0.45 |
| (二)稀释每股收益 | 0.8 | 0.56 | 0.43 | 0.44 |
| 九、综合收益总额 | 126,971,331.2 | 88,917,856.49 | 47,080,862.26 | 49,835,372.49 |
| 归属于母公司股东的综合收益总额 | 127,010,169.16 | 88,956,694.45 | 47,119,700.22 | 50,023,708.92 |
| 归属于少数股东的综合收益总额 | -38,837.96 | -38,837.96 | -38,837.96 | -188,336.43 |
| 公告日期 | 2025-10-28 | 2025-08-15 | 2025-04-25 | 2025-04-25 |
| 审计意见(境内) | | | | 标准无保留意见 |